Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor

Physical Biology

Volumn 10, Issue 3, 2013, Pages

  Tormoen, Garth W ^a   Khader, Ayesha ^a   Gruber, András ^a,b   McCarty, Owen J T ^a,b,c  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; THROMBOPLASTIN;

BLOOD CLOTTING; HEMODYNAMICS; HUMAN; KINETICS; METABOLISM; ARTICLE;

BLOOD COAGULATION; FACTOR IX; FACTOR X; HEMODYNAMICS; HUMANS; KINETICS; THROMBOPLASTIN;

EID: 84878887214     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/10/3/036003     Document Type: Article

References (38)

1. Iodice S, Gandini S, Lohr M, Lowenfels A B and Maisonneuve P 2008 Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis J. Thromb. Haemost. 6 781-8 (Pubitemid 351524538)
2. Sorensen H T, Mellemkjaer L, Olsen J H and Baron J A 2000 Prognosis of cancers associated with venous thromboembolism New Engl. J. Med. 343 1846-50 (Pubitemid 32104130)
3. Tormoen G W, Haley K M, Levine R L and McCarty O J 2012 Do circulating tumor cells play a role in coagulation and thrombosis? Front. Oncol. 2 115
4. Trousseau A 1865 Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu de Paris (Paris: The Syndenham Society) pp 654-712
5. Chew H K, Wun T, Harvey D, Zhou H and White R H 2006 Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch. Intern. Med. 166 458-64
6. Chew H K, Davies A M, Wun T, Harvey D, Zhou H and White R H 2008 The incidence of venous thromboembolism among patients with primary lung cancer J. Thromb. Haemost. 6 601-8 (Pubitemid 351404927)
7. Berny-Lang M A et al 2011 Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells Phys. Biol. 8 015014
8. Tormoen G W, Cianchetti F A, Bock P E and McCarty O J 2012 Development of coagulation factor probes for the identification of procoagulant circulating tumor cells Front. Oncol. 2 110
9. Tormoen G W, Rugonyi S, Gruber A and McCarty O J 2011 The role of carrier number on the procoagulant activity of tissue factor in blood and plasma Phys. Biol. 8 066005
10. Welsh J, Smith J D, Yates K R, Greenman J, Maraveyas A and Madden L A 2012 Tissue factor expression determines tumour cell coagulation kinetics Int. J. Lab. Hematol. 34 396-402
11. Zwicker J I et al 2009 Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin. Cancer Res. 15 6830-40
12. Khorana A A et al 2008 Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J. Thromb. Haemost. 6 1983-5
13. Thaler J et al 2011 Circulating procoagulant microparticles in cancer patients Ann. Hematol. 90 447-53
14. Auwerda J J et al 2011 Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma Thromb. Haemost. 105 14-20
15. Giesen P L et al 1999 Blood-borne tissue factor: another view of thrombosis Proc. Natl Acad. Sci. USA. 2 2311-5 (Pubitemid 29117911)
16. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C and Furie B 2004 Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation Blood 104 3190-7 (Pubitemid 39507134)
17. Falati S et al 2003 Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin J. Exp. Med. 197 1585-98 (Pubitemid 36682554)
18. Lee A M, Tormoen G W, Kanso E, McCarty O J and Newton P K 2012 Modeling and simulation of procoagulant circulating tumor cells in flow Front. Oncol. 2 108
19. McGee M P, Li L C and Xiong H 1992 Diffusion control in blood coagulation. Activation of factor X by factors IXa/VIIIa assembled on human monocyte membranes J. Biol. Chem. 267 24333-9
20. Dielis A W et al 2008 Coagulation factors and the protein C system as determinants of thrombin generation in a normal population J. Thromb. Haemost. 6 125-31
21. Brummel-Ziedins K E, Pouliot R L and Mann K G 2004 Thrombin generation: phenotypic quantitation J. Thromb. Haemost. 2 281-8 (Pubitemid 40186043)
22. Mandala M et al 2010 Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial Ann. Oncol. 21 871-6
23. Ay C et al 2011 Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study J. Clin. Oncol. 29 2099-103
24. Tucker E I et al 2009 Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI Blood 113 936-44
25. Berny M A et al 2010 Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear PLoS One 5 e10415
26. Tesselaar M E, Romijn F P, Van Der Linden I K, Prins F A, Bertina R M and Osanto S 2007 Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J. Thromb. Haemost. 5 520-7 (Pubitemid 46680685)
27. Manly D A et al 2010 Increased microparticle tissue factor activity in cancer patients with venous thromboembolism Thromb. Res. 125 511-2
28. Gemmell C H, Turitto V T and Nemerson Y 1988 Flow as a regulator of the activation of factor X by tissue factor Blood 72 1404-6 (Pubitemid 18265912)
29. Fair D S 1983 Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay Blood 62 784-91 (Pubitemid 13008666)
30. Yang H C 1978 Immunologic studies of factor IX (Christmas factor): II. Immunoradiometric assay of factor IX antigen Br. J. Haematol. 39 215-24 (Pubitemid 8372836)
31. Epstein D J, Bergum P W, Bajaj S P and Rapaport S I 1984 Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states Am. J. Clin. Pathol. 82 573-81 (Pubitemid 15203678)
32. Hoyer L, Wyshock W and Colman R 1994 Hemostasis and Thrombosis: Basic Principles and Clinical Practice 3rd edn (Philadelphia, PA: J B Lippincott)
33. Kamphuisen P W, Rosendaal F R, Eikenboom J C, Bos R and Bertina R M 2000 Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels Arterioscler. Thromb. Vasc. Biol. 20 1382-6 (Pubitemid 30262942)
34. Ceelie H, Bertina R M, van Hylckama Vlieg A, Rosendaal F R and Vos H L 2001 Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels Thromb. Haemost. 85 1066-70 (Pubitemid 32573761)
35. Legnani C et al 2003 Venous thromboembolism, oral contraceptives and high prothrombin levels J. Thromb. Haemost. 1 112-7
36. von Ahsen N, Lewczuk P, Schutz E, Oellerich M and Ehrenreich H 2000 Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation Thromb. Res. 99 549-56 (Pubitemid 30642734)
37. Karnicki K, Owen W G, Miller R S and McBane R D 2nd 2002 Factors contributing to individual propensity for arterial thrombosis Arterioscler. Thromb. Vasc. Biol. 22 1495-9
38. Zhang H et al 2010 Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk Blood 116 4684-92